Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Understand the source comparison

TB-4 Dosage Protocol: Reconstitution, Storage, and Administration Comparison

Typical Dosage Range 4–6mg weekly, split into 2 injections (e.g., 2mg Monday, 2mg Thursday) 2–4mg weekly or biweekly as single injection Unreconstituted: store at −20°C; reconstituted: 2–8°C, use within 28 days Higher loading doses establish tissue saturation;

No winner is assigned.

This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.

  • Typical Dosage Range
  • 4–6mg weekly, split into 2 injections (e.g., 2mg Monday, 2mg Thursday)
  • 2–4mg weekly or biweekly as single injection
  • Unreconstituted: store at −20°C; reconstituted: 2–8°C, use within 28 days
  • Higher loading doses establish tissue saturation; maintenance sustains effects without receptor downregulation risk
  • Injection Frequency
  • Twice weekly (every 3–4 days) to maintain plasma levels above threshold
  • Once weekly or biweekly depending on response and research timeline
  • Avoid freeze-thaw cycles. Aliquot if necessary before freezing
  • Frequent early dosing compensates for short 10-hour circulating half-life
  • Reconstitution Volume
  • 2mL bacteriostatic water per 5mg vial = 2.5mg/mL concentration
  • Same. Consistency in concentration prevents dosing errors
  • Inject bacteriostatic water slowly down vial wall, never shake, swirl gently until dissolved
  • Correct dilution math is non-negotiable. Errors here mean wasted peptide or ineffective dosing
  • Injection Route
  • Subcutaneous (abdominal, deltoid, or near injury site if localized study)
  • Subcutaneous, systemic sites preferred for maintenance
  • Rotate injection sites to prevent lipohypertrophy or tissue irritation
  • Subcutaneous absorption reaches peak plasma in 30–60 minutes; IM offers no advantage
  • Temperature Control
  • Ship with cold packs; transfer to freezer immediately upon receipt
  • After reconstitution, refrigerate. Never refreeze
  • Any excursion above 8°C risks denaturation; visual clarity is not a potency indicator
  • Temperature discipline matters more than dosage precision. Heat-damaged TB-4 is biologically inactive
  • Contamination Risk
  • Use sterile technique. Alcohol swabs, clean work surface, no touch transfer
  • Always use fresh needle for drawing and separate needle for injection
  • Bacteriostatic water inhibits bacterial growth but does not sterilize; aseptic technique required
  • Contaminated vials can cause injection site reactions or systemic infection